SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurex Corporation -- Ignore unavailable to you. Want to Upgrade?


To: Roger Bodine who wrote (445)3/7/1999 5:52:00 PM
From: NeuroInvestment  Read Replies (2) | Respond to of 449
 
The NDA for ziconotide in both chronic and neuropathic pain will be filed by April most likely--the FDA requested additional longterm followup safety data. With a year to go through the approval process, ziconotide likely will not be on the market until 2Q:2000. NeuroInvestment (www.neuroinvestment.com)